✦ LIBER ✦
Glioblastoma: synergy of growth promotion between CCL5 and NK-1R can be thwarted by blocking CCL5 with miraviroc, an FDA approved anti-HIV drug and blocking NK-1R with aprepitant, an FDA approved anti-nausea drug
✍ Scribed by R. E. Kast
- Book ID
- 108849345
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 112 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0269-4727
No coin nor oath required. For personal study only.